Early data suggests GLP-1 drugs, renowned for their ability to assist in weight loss, may have a powerful effect on treating addiction.
https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png00https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png2024-10-18 09:41:402024-10-18 09:41:40Why We May Soon Use Ozempic to Treat Addiction
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.